References
- Bachmann F, McKenna R, Cole E R, Najati H. The hemostatic mechanism after open-heart surgery. J Thorac Cardiovasc Surg 1975; 70: 76–85
- Bagge L, Lilienberg G, Nyström S O, Tydén H. Coagulation, fibrinolysis and bleeding after open-heart surgery. Scand J Thor Cardiovasc Sure 1986; 20: 151–151
- Chenoweth D E, Cooper S W, Hugli T E, Stewart R W, Blackstone E H, Kirklin J W. Complement activation during cardiopulmonary bypass. New Engl J Med 1981; 304: 497–503
- Clark R E, Beauchamps R A, Magrath R A, Brooks J D, Ferguson T B, Weldon C S. Comparison of bubble and membrane oxygenators in short and long perfusions. J Thorac Cardiovasc Surg 1979; 78: 655–666
- Craddock P R, Fehr J, Dalmasso A P, Brigham K L, Jacobs H S. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 1977; 59: 879–888
- van den Dungen J JAM, Karliczek G F, Brenken U, Homan van der Heide J N, Wildevuur C RH. Clinical study of blood trauma during perfusion with membrane and bubble oxygenators. J Thorac Cardiovasc Surg 1982; 83: 108–116
- Hellem A J. Platelet adhesiveness in von Willebrand's disease: A study with a new modification of the glass beads method. Scand J Med 1970; 7: 374–382
- Hessel E A, Johnson D D, Ivey T D, Miller D W. Membrane versus bubble oxygenator for cardiac operations. J Thorac Cardiovasc Surg 1980; 80: 111–112
- Mammen E F, Koets M H, Washington B C. Hemostasis changes during cardiopulmonary bypass surgery. Seminars in Thrombosis and Haemostasis 1985; 2: 281–292
- Nilsson L, Nilsson U, Venge P, et al. Inflammatory system activation during cardiopulmonary bypass as an indicator of biocompatibility: A randomized comparison of bubble and membrane oxygenators. Scand J Thor Cardiovasc Surg 1990; 24: 53–58
- van Oeveren W, Kazatchkine M D, Descamps-Lat-Scha B, et al. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation. J Thorac Cardiovasc Surg 1985; 89: 888–899
- Olofsson T, Olsson I, Venge P. Myeloperoxidase and lactoferrin of blood neutrophils and plasma in chronic granulocytic leukemia. Scand J Haematol 1977; 18: 113–120
- Riegel W, Spillner G, Schlosser V, Hörl W H. Plasma levels of main granulocyte components during cardio-pulmonary bypass. J Thorac Cardiovasc Surg 1988; 95: 1014–1019
- Sade R M, Bartles D M, Dearing J P, Campbell L J, Loadholt C B. A prospective randomized study of membrane versus bubble oxygenators in children. Ann Thorac Surg 1980; 29: 502–511
- Salama A, Hugo F, Heinrich D, et al. Deposition of terminal C5b-9 complement complexes on erythro-cytes and leukocytes during cardiopulmonary bypass. New Engl J Med 1988; 318: 408
- Thelin S, Hultman J, Jakobson S, Juhlin C, Hansson H E, Ronquist G. Functional effects of phosphoenol-pyruvate and ATP on pig hearts in cardioplegia and during reperfusion. An in vivo study with cardiopulmonary bypass. Eur Surg Res 1987; 19: 348–356
- Walker I D, Davidson J F, Hutton I. “Fibrinolytical potential”. The response to a 5 minute venous occlusion test. Thromb Res 1976; 8: 629–638